Krishnamoorthy Narayanan, Simpson Colin D, Townend John, Helms Peter J, McLay James S
Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, Scotland.
J Adolesc Health. 2008 Jan;42(1):97-101. doi: 10.1016/j.jadohealth.2007.06.016. Epub 2007 Oct 4.
The aim of this study was to assess change in the number of adolescent females prescribed hormonal contraception in primary care following the publication in the United Kingdom of the Social Exclusion Unit report on Teenage Pregnancy.
We conducted a retrospective observational study of 320 primary care practices in Scotland. Hormonal contraceptive prescribing to girls aged <16 years and those aged 16-19 years was assessed for April 1 to March 31 for the study years 2000-2001 to 2005-2006 from Scottish primary care practice data.
Between 2000-2001 and 2005-2006, the proportion of girls aged <16 years and those 16-19 years who were prescribed hormonal contraception by their primary care physicians increased by 82% (p < .001) and 53% (p < .001) respectively. The increase became significant from age 12 years for the combined oral contraceptive, 14 years for the progestogen-only pill, and 15 years for depot progestogens. By 2005-2006, 2.9% of girls aged <16 years and 40.5% of those aged 16-19 years were prescribed some form of hormonal contraception by their primary care physicians. The small number of girls aged <12 years who were prescribed hormonal contraception remained constant over the study period.
Since the publication in the United Kingdom of the Social Exclusion Unit Report on Teenage Pregnancy, there has been a significant increase in the number of female adolescents aged > or =12 years prescribed hormonal contraception by their primary care physicians. However the number of individuals prescribed hormonal contraception still remains relatively low in comparison to the reported levels of sexual activity among adolescents in the United Kingdom.
本研究旨在评估英国社会排斥问题小组发布关于青少年怀孕的报告后,初级保健机构中开具激素避孕药物的青春期女性数量的变化。
我们对苏格兰的320家初级保健机构进行了一项回顾性观察研究。根据苏格兰初级保健机构的数据,对2000 - 2001年至2005 - 2006年研究年度4月1日至3月31日期间,为年龄小于16岁和16 - 19岁女孩开具激素避孕药物的情况进行了评估。
在2000 - 2001年至2005 - 2006年期间,年龄小于16岁和16 - 19岁的女孩中,由初级保健医生开具激素避孕药物的比例分别增加了82%(p <.001)和53%(p <.001)。复方口服避孕药在12岁、仅含孕激素的药丸在14岁、长效孕激素在15岁时,开具量的增加变得显著。到2005 - 2006年,年龄小于16岁的女孩中有2.9%、16 - 19岁的女孩中有40.5%由初级保健医生开具了某种形式的激素避孕药物。在研究期间,年龄小于12岁且开具激素避孕药物的女孩数量保持不变。
自英国社会排斥问题小组发布关于青少年怀孕的报告以来,年龄大于或等于12岁的女性青少年中,由初级保健医生开具激素避孕药物的数量显著增加。然而,与英国报告的青少年性行为水平相比,开具激素避孕药物的人数仍然相对较低。